Sangamo Biosciences, Inc. (NASDAQ:SGMO)

CAPS Rating: 3 out of 5

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

Recs

1
Player Avatar pchop123 (80.45) Submitted: 2/22/2013 1:42:29 PM : Outperform Start Price: $8.78 SGMO Score: +20.17

good entry point

Featured Broker Partners


Advertisement